Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Covid-19 and the Human Gut: A New Runner on the Tract

Lerner Aaron

Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Abstract: The severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) dwells in the respiratory airways, however, its digestive tract presence, infectivity, mucosal attachment and penetrating mechanisms, enteric proliferation, stool shading, flashed bio-aerosol spreading and fecal-oral transmission is far from being understood. The present review opens some skylights to lighten the long, tortuous, dark and challenging tunnel of the gastrointestinal tract and his uninvited covid-19 viral new inhabitant.

Keywords: covid-19, SARS-CoV-2, corona virus, gut, intestine, gastrointestinal tract, endoscopy, stool, infectivity, transmission

Received May 01, 2020; Revised June 05, 2020; Accepted June 25, 2020

Citation: Lerner Aaron, Covid-19 and the Human Gut: A New Runner on the Tract. International Journal of Celiac Disease, 8 (2). 64-67. January 2020. doi:10.12691/ijcd-8-2-7

1. Introduction

At the end of 2019, the Chinese Wuhan's health authorities were investigating cases of an acute respiratory syndrome. The epidemiologic investigation linked the respiratory distress to a local Seafood Market. Quite quickly genomic analysis linked the etiology to a new virus, a member of the coronavirus family, initially named 2019 novel coronavirus (2019-nCoV). Today the virus is called coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. The name SARS directs the target organ of the virus to the upper respiratory ways and lungs, but it appears that the gastrointestinal tract is also affected. The present review intends to summarize and update the readers on the enteric aspects of the covid-19.

1.1. Covid-19 Update

In his latest brief, the world health organization-director-general declared that in the currently evolving Pandemic, more than 2 million cases of COVID-19 have now been reported to his organization, sadly enough, more than 135,000 people have lost their lives worldwide [2]. It is the third outbreak of a Coronavirus in the present century, following the SARS and the MARS epidemics, few years ago. Understand and prevent pathogens crossing from animals to humans is crucial since an estimated 70% of all new viruses come from animals. The two past epidemic animal sources, the Himalayan palm civet for SARS-CoV and the dromedary camel for MERS-CoV were detected, not yet for the origin of the new SARS-CoV-2 [3,4]. To date, the COVID-19 outbreak spread to 6 continents, affected most of the countries and represents a global health concern with an estimated case-fatality rate of 2-3%. Coronaviruses are RNA viruses like influenza, however, the present SARS-CoV-2 is more contagious, more aggressive and fatal than the winter outbreaks of the influenza viruses. There are already two variants for SARS-CoV-2, the L type and the S type that were identifies and most probably, according to virologists, it will continue to mutate. The viruses are on our planet for more than 4 billion years, compared to the homo sapience who resides here for only 1-2 million years [5]. The novel phenomenon of the covid-19 entry into a new species, namely, human being, represent a new evolutionary event that our immune barriers has to detect and react accordingly. Over reaction like the cytokine storm, might be detrimental [6]. It adapts to a more efficient and more capable replication in that new host species and more efficient transmission between the infected species. It can be generalized that till herd immunity will develop, any person without pre-existing immunity is susceptible to the covid-19 infection [7]. Finally, being a new human viral infection, the covid-19 present much more questions than answers. Its origin, biology, epidemiology, infectivity, short and long-term pathology and complications, specific immune protective mechanisms and effective mode of therapies are far from being elucidated [1,4,8,9].

1.2. The Gastrointestinal Virome and Phageome

An ocean of information and expending scientific knowledge is available on the enteric microbiotic composition and diversity in human development and homeostasis while the dysbiotic morbidity in specific human chronic disease is still evolving. In fact, the gut microbes are extensively explored, but, the enteric virus's incidence, characterization, biology, functions and relations with their prokaryotic neighbors are still in the initial steps of exploration. In fact, more and more knowledge is accumulating regarding intestinal luminal viruses and bacteriophages. It appears that they outnumber bacteria in a ratio of 10:1 [10]. Being an absolute parasite, they penetrate microbes, integrate their genetic material into the host genome, thus, dominating their destiny [11]. The outcome is microbial deadly lysis or a transient symbiotic relation when integration of the viral genetic sequences into the host genome is occurring. The later possibility is called lysogeny [12]. The enteric phageome (collection of bacteriophages) is crucial in orchestrating the homeostatic maintenance of the luminal microbiome composition, diversity and functionality. Comparably to the dysbiome, the list of phageomic aberrations in specific human pathologies is expanding. Crohn's disease, ulcerative colitis, type 2 diabetes and celiac disease are some examples [13]. When a pathological virome invades the gastrointestinal (GI) luman it can induce acute or chronic gastroenteritis and once in a while a devastating outbreak or epidemies. Enteroviruses, rotavirus, Hepatitis A, poliovirus are such an example. The present review will introduce a new virus that strikes the globe right now with a severe Pandemic, namely, the covid-19, a member of the coronavirus family that invades our GI tract.

2. Gastrointestinal Aspects

Most of the epidemiological, clinical and pathological publications on covid-19 virus concentrate on the upper and lower respiratory tracts [14]. Despite this, other organs like kidney, liver, heart, vessels and intestine are also affected. Follow bellow is the place of the GI tract in the SARS-CoV-2 puzzle.

2.1. Symptoms

Covid-19 cohabit the enteric tract and some presenting symptoms and enteric complains were described in Wuhan, Chine and outside of Wuhan. Out of 651 patients, 11.4% presented with at least one GI symptom like nausea, vomiting or diarrhea. Interestingly, patients with GI symptoms had more severe or critical picture and family clustering, compared to those without GI symptomatology [15]. In another Chinese province, in Zhejiang, 8% of the hospitalized patients had diarrhea [16] and in a study from Wuhan, diarrhea occurred in 49.5% of the patients [17]. Some patients with diarrhea don’t have respiratory symptoms while the debate about digestive symptoms in the more severe compared to the non-severe patients is unresolved. Diarrhea as presenting symptom was described in elderly, adults and children [18]. It appears that along the Chinese epidemics, in the later stage, the proportion of patients with diarrhea increased when compared with the pre‐epidemic stage. At least, 12 infected patients had GI bleeding and the rate of diarrhea in children was similar (9.6%‐15%) as adults but they had a higher rate of vomiting [18].

According to a very recent report from Wuhan, 31% of patients with covid-19 induced pneumonia had diarrhea. A higher proportion of patients with diarrhea had viral RNA in stool than patients without diarrhea. Intriguingly, elimination of SARS-CoV-2 from stool took longer than elimination from the nose and throat [19]. Even asymptomatic or hypo-symptomatic SARS-Cov-2 positive infant can excrete the virus in their stool without any diarrhea [20]. Finally, abdominal pains accompany patients with GI symptomatology [21] but, anorexia was reported as the most common GI symptom [18].

2.2. Pathophysiology and Pathology

The Spike protein is a homotrimers that protrude from the covid-19 surface, thus, facilitating the attachment of the viral envelope to host cells by binding to its receptor, the angiotensin-converting enzyme 2 (ACE2) [22]. At the beginning of the covid-19 epidemy it was thought that this receptor is expressed in lower respiratory tract cells, explaining the respiratory symptoms and lung pathology. Later on, it was reported that ACE2 is highly expressed in esophageal epithelium, in the lining enterocytes from ileum and in the colonocytes of the colon [23]. The virus presence in the GI lumen in close proximity to its corresponding receptor strongly suggests the covid-19 can actively infect, replicate and induce enteric pathology with possible fecal transmission [3,14,17,18,19,20,21,23].

The GI topographic pathology induced by the SARS-CoV-2 involves all the gut segments, from the esophagus to the distal colon. The esophagus squamous epithelium might present lymphocytic infiltration and the stomach plasma cells and lymphocyte infiltrations and edema. The entire GI mucosa can present various degree of necrosis, degeneration and shedding of the epithelium [18,24]. The virus tropism of covid-19 to the GI mucosa was reported in several earlier studies. Nucleocapsid proteins and the virus itself was detected in cytoplasm of gastric, duodenal and colonic glandular epithelial cells, as well as in the stools [18,25,26]. Those pathological findings attest for the virus capacities to penetrate, attack and damage the GI tract and activate the host immune system to react against the invader.

2.3. Shading in Stools

Substantial evidences exist for the covid-19 virus cohabitation of the GI tract and for its stool excretion. Its stool presence can be detected even in asymptomatic patients, in all age ranges, including infants [17,18,19,20,21,25,26]. Interestingly enough, at least in asymptomatic patients, fecal excretion of this new coronavirus can last for 42 days, even when nasopharyngeal samples are negative [27]. The differential positivity of the swabs might change along the disease duration. The throat samples tend to be positive in the first days, while the rectal swabs, in the latter period of the infection [28]. The stool shading of the virus might explain the extensive infectivity and the pandemic extension of the covid-19.

2.4. Fecal Transmission Possibilities

In contrast to the well-established aerosol droplet's transmission, the topic of fecal transmission of the disease and the degree of infectivity of the stools is still unknown. Whenever discussing the subject, all the publications use the words: possible, potential or add a question mark [18,21,23,29,30,31]. Additionally, toilet stool flushing can produce bio-aerosols, thus enhancing contamination [31]. Historically, an index case of the Hong Kong SARS outbreak started with diarrhea suggesting a flashed bio-aerosol spreading [32]. Life pathogens are carried by bio-aerosols generated by water toilet flushing [33], small enough to be air-born infective messengers [34]. Most recently, the longer shedding of the SARS-CoV-2 was substantiated in children stools, compared to their respiratory tract. The authors concluded that other transmission routes, in addition to the droplet one, are also plausible [35]. Shedding seems to be present in feces for a longer time than in the respiratory tract of adults and children. Those are important implications for public health, transmission, infection control and future pandemic therapeutic strategies. The fecal transmission rout possibility, should be thoroughly investigated and not underestimated.

2.5. Covid-19 and Endoscopies

Despite the unresolved puzzle of fecal-oral transmission, the GI endoscopist team are warry about their professional safety and righteously so. The GI presence and fecal shading of the virus might put them at risk and the gastroscope/colonoscopes might represent a contaminated instrument that might spread the virus. Those are the reasons why various endoscopy and GI associations, originated from highly infected countries, put forward new guidelines to decrease the risks [36,37,38,39,40,41]. The guidelines cover pre, intra and post procedure recommendations. Adult's precautions are somewhat different from the pediatric ones, all present holistic approach to protect all the persons involved in the endoscopic procedures. Professional are encouraged to read the various recommendations and adopt them as necessary.

3. Conclusions

The SARS-CoV-2 is a new viral Pandemic that is spreading worldwide with more hidden knowledge than clinical and scientific facts. More and more information is accumulating on the GI symptoms, enteric dissemination and pathology, mechanism of mucosal attachment, fecal shading and potential fecal-oral transmission of the viral particle. Raising awareness, adapting suitable protective precautions and more attention to the undiscovered mode of dissemination is highly encouraged. It might change our contemporary struggle and improve public and the medical team safety and health.

References

[1]   | da Costa VG, Moreli ML, Saivish MV. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Arch Virol. 2020 Apr 22.
[2]   | https://www.who.int/dg/speeches/detail/who-director-general-s-opening- remarks-at-the-media-briefing-on-covid-19---17-april-2020.
[3]   | Lerner A. Are my patients with celiac disease at higher risk of COVID-19 virus? Internat J of Celiac Dis. 2020; 8: x-y.
[4]   | Rao K, Verma P, Kumar K, Verma MK, Siddiqui AH, et al. Review on Newly Identified Coronavirus and its Genomic Organization. SSR Inst. Int. J. Life Sci. 2020; 6(2): 2509-2519.
[5]   | Harari, Y.N. Sapiens: A Brief History of Humankind; Vintage Books: London, UK, 2011; pp. 1-466.
[6]   | Vaninov N. In the eye of the COVID-19 cytokine storm. Nat Rev Immunol. 2020 Apr 6.
[7]   | Kwok KO, Lai F, Wei WI, Wong SYS, Tang JWT. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect. 2020 Mar 21. pii: S0163-4453(20)30154-7.
[8]   | Wu, Yi-Chi, Chen, Ching-Sung, Chan, Yu-Jiun. The outbreak of COVID-19, J of the Chinese Med Assoc: March 2020; 83: 217-220.
[9]   | Valencia DN. Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2. Cureus 2020; 12: e7386.
[10]   | Mills, S.; Shanahan, F.; Stanton, C.; Hill, C.; Coffey, A.; Ross, R.P. Movers and shakers: Influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 2013; 4: 4-16.
[11]   | Manrique P, Dills, M, Young, MJ. The Human Gut Phage Community and Its Implications for Health and Disease. Viruses 2017; 9: 141.
[12]   | Navarro F, Muniesa M. Phages in the Human Body. Front. Microbiol. 2017; 8: 566.
[13]   | Lerner A, Ramesh A, Matthias T. David and Goliath war revival in the enteric viruses and microbiota struggle. Potential implication for celiac disease. Microorganisms, 2019; 7: 173.
[14]   | Rothan HA, Byrareddy SN .The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109: 102433.
[15]   | Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020 Mar 24. pii: gutjnl-2020-320926.
[16]   | Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606.
[17]   | Fang D, Ma J, Guan J. et al. Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study. Chin J Dig. 2020, 40: [Epub ahead of print].
[18]   | Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020; 51: 843–851.
[19]   | Wei XS, Wang X, Niu YR, Ye LL, Peng WB, Wang ZH, et al. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19. Clin Gastroenterol Hepatol. 2020 Apr 17. pii: S1542-3565(20)30526-7. [Epub ahead of print].
[20]   | Kam KQ, Yung CF, Cui L, Lin Tzer Pin R, Mak TM, Maiwald M, et al. A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load. Clin Infect Dis. 2020 Feb 28. pii: ciaa201. [Epub ahead of print].
[21]   | Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol. 2020 Mar 25. [Epub ahead of print].
[22]   | Indwiani Astuti, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr. 2020 Apr 18. [Epub ahead of print].
[23]   | Zhang H, Kang Z, Gong H. et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv 927806. Post online Jan 31.
[24]   | Liu Q, Wang R., Qu G et al. Macroscopic autopsy findings in a patient with COVID-19. J Forensic Med. 2020;36:1-3.
[25]   | Yang Z, Li G, Dai X, Liu G, Li G, Jie Y. Three cases of novel coronavirus pneumonia with viral nucleic acids still positive in stool after throat swab detection turned negative. Chin J Dig. 2020;40:E002–E002.
[26]   | Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol. 2020. Published online Mar 3.
[27]   | Jiang X, Luo M, Zou Z, Wang X, Chen C, Qiu J. Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days. J Med Virol. 2020 Apr 24.
[28]   | Ozma MA, Maroufi P, Ehsaneh Khodadadi E, Köse SU, Esposito I, Ganbarov K, et al. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Le Infezioni in Medicina, 2020;2:153-165.
[29]   | Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology. 2020 Mar 3. pii: S0016-5085(20)30281-X. [Epub ahead of print]
[30]   | Hindson J. COVID-19: faecal-oral transmission? Nat Rev Gastroenterol Hepatol. 2020 Mar 25. [Epub ahead of print]
[31]   | McDermott CV, Alicic RZ, Harden N, Cox EJ, Scanlan JM. Put a lid on it: Are faecal bio-aerosols a route of transmission for SARS-CoV-2? J Hosp Infect. 2020 Apr 18. pii: S0195-6701(20)30199-7. [Epub ahead of print].
[32]   | Yu I T., Li Y., Wong TW, Tam W, Chan AT, Lee JH. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med. 2004; 350: 1731-1739.
[33]   | Knowlton SD, Boles CL, Perencevich EN, Diekema DJ, Nonnenmann MW, CDC Epicenters Program Bioaerosol concentrations generated from toilet flushing in a hospital-based patient care setting. Antimicrob Resist Infect Control. 2018;7:16.
[34]   | Johnson D, Lynch R, Marshall C, Mead K, Hirst D. Aerosol Generation by Modern Flush Toilets. Aerosol Sci Technol. 2013; 47: 1047-1057.
[35]   | Santana SV, Queiroz GR, Eduardo CL, Ricardo M-FP. Prolonged fecal shedding of SARS-CoV-2 in pediatric patients. A quantitative evidence synthesis. J of Pediatr Gastroenterol and Nutr.: May 22, 2020, [Epub ahead of Print].

[36]  
Sociedad Española de Patología Digestiva; Asociación Española de Gastroenterología. Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18). Rev Esp Enferm Dig. 2020 Mar 23.

[37]   | Repici A, Maselli R, Colombo M, Roberto Gabbiadini R, Spadaccini M, Anderloni A, et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest Endosc 202 Mar 13.
[38]   | https://gi.org/2020/03/15/joint-gi-society-message-on-covid-19/COVID-19 Clinical Insights for Our Community of Gastroenterologists and Gastroenterology Care Providers. Posted on March 15, 2020 by the American College of Gastroenterology News Team.
[39]   | Walsh CM, Fishman DS, Lerner DG, NASPGHAN Endoscopy and Procedures Committee. Pediatric Endoscopy in the Era of COVID-19: A NASPGHAN Position Paper. J of Pediatr Gastroenterol and Nutr, 2020.
[40]   | Murray KF, Gold BD, Shamir R, Agostoni C, Pierre-Alvarez R, Kolacek S, et al. COVID-19 and the Pediatric Gastroenterologist. J of Pediatr Gastroenterol and Nutr.
[41]   | Sinonquel P, Roelandt P, Demedts I, van Gerven L, Vandenbriele C, Wilmer A, et al. COVID-19 and gastrointestinal endoscopy: what should be taken into account? Dig Endosc. 2020 Apr 26.